Recently, the FDA approved our medicine as a treatment for certain people with newly-diagnosed acute myeloid leukemia (AML) or those who are ineligible for intensive induction chemotherapy. Watch the video below to learn about #AML, the most common type of aggressive #leukemia in adults. http://ow.ly/FEra50jL2ZM | Genentech

Red 6: the future of combat pilot training with augmented reality Red 6 is developing an Airborne Tactical Augmented Reality System to enhance training capabilities and the war fighter with highly accurate, high-fidelity simulation in the air. Read more here: https://skiesmag.com/news/red-6-future-combat-pilot-training-augmented-reality/ | Skies Plus